Article from Japan Chemical Daily.
"Regeneus has already commenced and continues preparation for further PMDA consultations for their Japan phase II clinical trial. They have also further progressed manufacturing preparation for this trial through commencing donor selection and manufacturing process development. AGC will be responsible for the GMP production of Progenza for the Japan clinical trial."
http://regeneus.com.au/media/news/JapanChemicalDailyArticle.pdf
Ann: Japanese Patent Office to grant key patent for Progenza, page-16
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
